Physician profile
Christopher Keel
NPI 1619111200
$67,666.39
in general payments reported to CMS, 2019-2025
55 companies · $5,433 in 2025
The $5,433 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,524 · 2020: $5,089 · 2021: $4,980 · 2022: $24K · 2023: $19K · 2024: $5,582 · 2025: $5,433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $16K · Food and Beverage: $8,029 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,630 · Travel and Lodging: $2,392 · Gift: $23.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $16,035.06 |
| Food and Beverage | $8,028.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,630.00 |
| Travel and Lodging | $2,392.24 |
| Gift | $23.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $54,461.38 | 2019-2024 | Da Vinci Surgical System |
| Janssen Biotech, INC. | $4,713.73 | 2019-2025 | Carvykti, Rybrevant, Erleada |
| Medtronic, INC. | $1,575.63 | 2021-2025 | Interstim, Altaviva |
| Abbvie INC. | $540.97 | 2022-2025 | |
| Antares Pharma, INC. | $517.39 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Myriad Genetic Laboratories, INC. | $447.19 | 2021-2025 | Prolaris |
| Astellas Pharma US INC | $443.50 | 2019-2024 | Xtandi |
| Dendreon Pharmaceuticals LLC | $439.84 | 2019-2025 | Provenge |
| Boston Scientific Corporation | $356.22 | 2019-2025 | Ams 700 |
| Neotract INC. | $319.47 | 2019-2020 | |
| Karl Storz Endoscopy-America | $318.76 | 2020-2023 | N.A. |
| Coloplast Corp | $279.36 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $250.70 | 2022-2025 | Lynparza, Keytruda |
| Baxter Healthcare | $245.19 | 2019-2025 | Tisseel, Floseal, Perclot |
| Janssen Scientific Affairs, LLC | $213.52 | 2019-2025 | Erleada, Akeega |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $212.05 | 2023-2025 | Orgovyx, Gemtesa |
| Allergan, INC. | $178.08 | 2019-2022 | |
| Olympus America INC. | $170.13 | 2022-2024 | Itind System |
| Photocure INC | $148.74 | 2021-2024 | Cysview |
| Urogen Pharma, INC. | $146.36 | 2022-2025 | Jelmyto |
| Pfizer INC. | $123.38 | 2019-2025 | |
| Procept Biorobotics Corporation | $121.85 | 2024-2025 | Aquabeam System |
| Novartis Pharmaceuticals Corporation | $120.22 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $104.62 | 2019-2025 | Imfinzi |
| Laborie Medical Technologies Corp. | $84.41 | 2024 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| C. R. Bard, INC. & Subsidiaries | $78.54 | 2020 | |
| Blue Earth Diagnostics | $76.83 | 2021-2025 | Posluma |
| Accord Healthcare, INC. | $73.81 | 2022-2023 | |
| Myovant Sciences INC. | $73.56 | 2022 | |
| Immunitybio, INC. | $69.65 | 2025 | |
| Teleflex LLC | $67.63 | 2025 | Urolift |
| Endo Pharmaceuticals INC. | $64.71 | 2019-2022 | |
| 180 Medical, INC. | $64.34 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $45.78 | 2025 | Adstiladrin |
| Endo USA, INC. | $40.65 | 2025 | Xiaflex, Aveed |
| Progenics Pharmaceuticals, INC. | $38.23 | 2023-2024 | Pylarify |
| Blueprint Medicines Corporation | $38.07 | 2020-2021 | |
| Agiliti Surgical, INC. | $35.28 | 2019-2024 | Koelis Trinity Fusion Biopsy System, Sonablate Hifu, Endocare Cryocare Cs System |
| Tolmar, INC. | $34.87 | 2024 | |
| Medtronic USA, INC. | $31.20 | 2019 | |
| Coopersurgical, INC. | $29.21 | 2025 | Ally II Ups |
| Abc Home Medical Supply, INC. | $28.58 | 2022 | |
| Halozyme INC | $28.54 | 2023 | |
| Telix Pharmaceuticals | $27.68 | 2023-2024 | Illuccix |
| Astellas Pharma Global Development | $26.73 | 2019 | |
| Axonics, INC. | $25.39 | 2020 | |
| Novo Nordisk INC | $23.46 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.77 | 2025 | |
| Mission Pharmacal Company | $18.60 | 2023 | Lithostat |
| Amag Pharmaceuticals, INC. | $16.26 | 2019 | |
| Bard Access Systems, INC. | $15.92 | 2019 | |
| Ambu INC. | $15.32 | 2022 | |
| Lsi Solutions INC | $13.12 | 2024 | Running Device, Ti-Knot, Jnw Urtrac |
| Rochester Medical Corporation | $12.97 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Keel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.